Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer (Q30485336)

13 October 2017

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer (English)

1 reference

13 October 2017

1 reference

8

Alan W Partin

1 reference

13 October 2017

10

William B Isaacs

1 reference

13 October 2017

9

Robert L Vessella

1 reference

13 October 2017

Rong Hu

1

1 reference

13 October 2017

Thomas A Dunn

2

1 reference

13 October 2017

Shuanzeng Wei

3

1 reference

13 October 2017

Sumit Isharwal

4

1 reference

13 October 2017

Robert W Veltri

5

1 reference

13 October 2017

Elizabeth Humphreys

6

1 reference

13 October 2017

Misop Han

7

1 reference

13 October 2017

G Steven Bova

11

1 reference

13 October 2017

Jun Luo

12

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

13 October 2017

1 reference

13 October 2017

69

1 reference

13 October 2017

1

1 reference

13 October 2017

16-22

1 reference

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Androgen receptor structural and functional elements: role and regulation in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

New drugs in prostate cancer.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Androgen receptor in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Isoform/variant mRNAs for sex steroid hormone receptors in humans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Molecular biology of the androgen receptor

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Formation of the androgen receptor transcription complex

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Delineation of prognostic biomarkers in prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614301

Genetic aberrations in prostate cancer by microarray analysis

26 November 2018

1 reference

12 December 2020

Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues

1 reference

12 December 2020

A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences

1 reference

12 December 2020

Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo

1 reference

12 December 2020

10.1158/0008-5472.CAN-08-2764

Identifiers

DOI

1 reference

13 October 2017

1 reference

13 October 2017

1 reference